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INTRODUCTION
Sarcoidosis is a chronic multisystem granulomatous 
disease characterized by the presence of non‑caseating 
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Abstract
Purpose: To compare the involvement of the retina with that of the choroid in ocular sarcoidosis (OS) using 
dual fluorescein angiography (FA)/indocyanine green angiography (ICGA).
Methods: A retrospective study of 23 patients with the diagnosis of OS was performed. Angiographic signs 
were quantified following the established FA/ICGA scoring system for uveitis.
Results: The choroid was predominantly involved in 19 (82.6%) patients or 87% (40/46) of the eyes, and 
the retina in 2 (8.7%) patients or 13% (6/46) of the eyes. The mean angiographic score was 7.15 ± 4.5 for the 
retina (FA) compared to 14.02 ± 4.86 for the choroid (ICGA) (P < 0.0001). In 13% (3/23) of patients, FA did 
not show retinal inflammation, whereas ICGA was strongly positive, revealing occult choroidal lesions.
Conclusion: The choroid is preferentially involved in OS, for which ICGA is the examination of choice. There 
is a risk of underestimating the global ocular involvement and of missing choroidal involvement if only FA 
is used. FA/ICGA scoring system allows for quantitative assessment of inflammation in the posterior uvea 
that occurs in OS; therefore, the system can be useful to quantitatively monitor outcomes in clinical trials.
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granulomas in involved organs. The commonly affected 
organs are the lungs, skin, and eyes. The frequency 
of ocular involvement ranges from 25% to 80%. Most 
patients present between the ages of 20 and 40 years; 
however, children and the elderly can also be affected. 
Generally, ocular involvement appears early in the course 
of the disease and may co‑exist with asymptomatic 
systemic disease or precede systemic involvement by 
several years. The criteria for the diagnosis of ocular 
sarcoidosis (OS) were described by the first International 
J Ophthalmic Vis Res 2018; 13 (4): 426‑432
Access this article online
Quick Response Code:
Website:  
www.jovr.org
DOI:  
10.4103/jovr.jovr_201_17
How to cite this article: El Ameen A, Herbort CP Jr. Comparison of 
retinal and choroidal involvement in sarcoidosis-related chorioretinitis 
by using fluorescein and indocyanine green angiography. 
J Ophthalmic Vis Res 2018;13:426-32.
This is an open access journal, and articles are distributed under the terms of the 
Creative Commons Attribution‑NonCommercial‑ShareAlike 4.0 License, which 
allows others to remix, tweak, and build upon the work non‑commercially, as 
long as appropriate credit is given and the new creations are licensed under 
the identical terms.
For reprints contact: reprints@medknow.com
Journal of ophthalmic and Vision research Volume 13, Issue 4, october-December 2018 427
Retinochoroidal Involvement in Sarcoidosis; El Ameen and Herbort
Workshop on Ocular Sarcoidosis (IWOS).[1] Such criteria 
may have a higher sensitivity in the diagnosis of OS. 
Retinal involvement in OS has been well described 
based on studies using clinical fundus examination and 
fluorescein angiography (FA).[2] However, choroidal 
involvement and the difference between the rate 
of retinal and choroidal involvement could not be 
determined until a reliable method – such as indocyanine 
green angiography (ICGA) – was available to assess 
choroiditis and a scoring system was established to 
precisely measure choroidal and retinal angiographic 
signs. [3] The aim of this work was to assess the 
involvement of retina and that of the choroid in OS using 
dual fluorescein angiography (FA) and indocyanine 
green angiography (ICGA).[3,4]
METHODS
A retrospective study of patients with the diagnosis 
of OS that were seen between 2000 and 2016 at the 
Centre for Ophthalmic Specialized Care in Lausanne, 
Switzerland was performed. The diagnosis of OS was 
based on a compatible history of uveitis and a positive 
biopsy; a positive broncho‑alveolar lavage; bilateral hilar 
lymphadenopathy; or 2 of the following 3 laboratory 
abnormalities: elevated level of lysozyme, elevated 
level of angiotensin‑converting enzyme, or increased 
polyclonal activation.[5] In addition, patients had to have 
negative QuantiFERON‑TB Gold test. Patients presenting 
with sarcoidosis‑related chorioretinitis, as defined above, 
who had dual FA/ICGA data available were included 
in the study. All patients underwent the complete 
work‑up routinely applied to patients with uveitis. All 
patients in our center undergo a routine complete ocular 
assessment that, in addition to routine examinations 
such as Snellen visual acuity assessment, slit‑lamp 
examination, applanation tonometry, and dilated 
fundoscopy, includes the following investigations: laser 
flare photometry (LFP), computerized visual field (VF) 
testing, optical coherence tomography (OCT), and dual 
FA and ICGA since it became available. Laser flare 
photometric assessment was performed using a Kowa 
FM‑500 or Kowa FM‑700 device (Kowa Company, Ltd., 
Electronics and Optics Division, Tokyo, Japan), and 
OCT was performed using OTI‑Spectral OCT/SLO 
machine (OTI Inc., Toronto, Canada) or Heidelberg 
Spectralis OCT machine (Heidelberg Engineering Inc., 
Heidelberg, Germany). G1 program of the OCTOPUS 900 
perimeter (Octopus 900, G Standard; Haag Streit, Bern, 
Switzerland) was used for VF assessment.
Angiography
FA and ICGA were performed using a standard protocol 
described previously.[6] Briefly, FA and ICGA were 
usually performed simultaneously. A Topcon 50 IA 
camera (Tokyo, Japan) coupled to an image digitalizing 
system (ImageNet, Topcon)) or a Heidelberg Retina 
Angiograph HRA 2 system (Heidelberg Engineering Inc., 
Heidelberg, Germany) were used to acquire the images. To 
exclude autofluorescence, pre‑injection fluorescence was 
sought using the highest flash intensity used for ICGA. 
At the same time, red‑free posterior pole frames were 
acquired. After a bolus injection of 4 mg of indocyanine 
green (ICG) (Cardiogreen; Peaselt, Lorei, Germany) 
diluted in 5 ml of an aqua solution, ICGA frames of the 
posterior pole were acquired for approximately 2 to 
3 minutes (early phase angiogram). The ICG fluorescence 
pattern was analyzed in detail 12 ± 3 minutes after ICG 
injection (intermediate phase ICGA angiogram) by 
acquiring frames of the posterior pole and a minimum of 
eight frames of the whole periphery over 360°. At the end of 
the intermediate phase of ICGA, fluorescein angiography 
was performed. Early fluorescein angiographic frames 
of the posterior pole were acquired for 2 minutes. 
Between 4 and 7 minutes, 360° panoramic imaging of 
the periphery was performed (minimum eight frames), 
followed by acquisition of late fluorescein posterior 
pole frames at 10 minutes. The late ICG fluorescence 
pattern was analyzed 24 ± 4 minutes after ICG injection 
(late phase ICGA angiogram) in the same fashion as for 
the intermediate phase.
Angiographic Score
Fluorescein angiography and indocyanine green 
angiography were evaluated using a well‑established 
dual fluorescein angiography/indocyanine green 
angiography scoring system.[3,4] Briefly, a maximum total 
score of 40 was assigned to the FA signs, which included 
optic disc hyperfluorescence (maximum score [MS] = 3), 
macular edema (MS = 4), retinal vascular staining and/or 
leakage (MS = 7), capillary leakage (MS = 10), retinal 
capillary nonperfusion, neovascularization of 
the optic disc and neovascularization elsewhere, 
pinpoint leaks, and retinal staining and/or subretinal 
pooling (MS = 16). A maximum total score of 40 was 
also assigned to the ICGA signs, which included 
early stromal vessel hyperfluorescence (MS = 3), 
choroidal vasculitis (fuzzy vessels) (MS = 6), dark dots 
or areas (excluding atrophy) (MS = 8), and optic disc 
hyperfluorescence (MS = 3). Each ICGA scoring item was 
counting twice because the number of items in ICGA was 
half the number of items in FA; this was to ensure the 
proportionality of the scores in both methods.
The patients were classified into 3 categories, namely 
(1) choroidal involvement > retinal involvement 
(FA score < ICGA score), (2) retina involvement > choroidal 
involvement (FA score > ICGA score), and (3) choroidal 
involvement = retinal involvement (FA score = ICGA 
score). A score <3 points for FA or ICGA was interpreted as 
background noise and considered negative for involvement 
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of either of the two structures. Analysis of angiographic 
data was performed by two experienced angiography 
specialists (CPH and AE) in a masked fashion.
Standardization of Uveitis Nomenclature 
Vitreous Haze Scoring
Fundus images of all eyes were evaluated by two masked 
clinicians using the International SUN Vitreous Haze 
Score where the patient’s fundus picture was compared 
to a standard set of pictures with progressive importance 
of vitreous haze scored from 0 to 4.[7]
Statistical Analysis
We calculated the proportion of patients with ocular 
sarcoidosis in relation to the total number of patients 
with uveitis and the mean age of patients. In addition, 
we calculated the average angiographic score at the 
time of diagnosis as well as best‑corrected visual 
acuity (BCVA), intraocular pressure (IOP), LFP values, 
and FA and ICGA scores for all eyes. We also calculated 
the number of patients with a predominance of retinal 
involvement, those with predominance of choroidal 
involvement, as well as those with equal choroidal and 
retinal involvement. Furthermore, we calculated the 
number of cases with occult chorioretinal lesions only 
visible on ICGA or FA (scores <3). Finally, we calculated 
the vitreous haze score using the SUN scale[7] for each 
eye to evaluate its importance compared to that of 
angiographic scoring.
To compare these data, we used the paired t test. 
The inter‑observer variation was assessed using the 
intraclass correlation coefficient. Statistical significance 
was set at P < 0.05. Analysis was performed using 
MedCalc (version 17.7.2 for Windows; MedCalc 
Software; Ostend, Belgium). The study was performed 
in accordance with the ethical standards of the 
1964 Declaration of Helsinki and was approved by the 
institutional review board.
RESULTS
Demographic Characteristics
Among the 1325 patients with uveitis that were seen from 
2000 to 2016 at the Centre for Ophthalmic Specialized 
Care, 55 (4.15%) had or were presumed to have ocular 
sarcoidosis. Of the 55 patients, 23 (19 women and 4 men; 
mean age, 50.34 ± 20.15 years [range, 26‑80 years]) fulfilled 
the diagnostic criteria and were included in the study.
Visual Acuity,  Intraocular Pressure, 
Intraocular Inflammation, and Type of Uveitis
At presentation, the mean BCVA was 0.93 ± 0.30 
(0.067 ± 0.19 LogMAR) [Figure 1].
The mean IOP at presentation was 14.59 ± 3.63 
mm Hg.
Intraocular inflammation was measured using laser 
flare photometry, and the mean flare was 30 ± 38 ph/ms 
at presentation [Figure 2]. Ten patients presented with 
panuveitis with significant anterior uveitis. In the 13 
remaining patients, uveitis was limited to the posterior 
segment (posterior uveitis). Patients with pure anterior 
uveitis without posterior involvement were not included.
Fundus Findings
Fundus examination showed choroidal foci in only 14 
of the 23 patients. Vasculitis was seen in 4 patients; one 
of whom had a typical string‑of‑pearls appearance of 
vasculitis. Disc swelling was seen in 4 of the 23 patients, 
and macroaneurysms were present in 3 of the 23 patients. 
Fundus examination showed posterior inflammation in 
no more than half of the patients, whereas FA/ICGA 
was positive in all patients and appeared to be essential 
in establishing the presence and determining the extent 
of the posterior inflammation.
Angiographic Findings
The intraclass correlation coefficient was 0.9848 for the 
angiographic score and 0.9595 for the vitreous haze 
classification; these values, showed there was a high 
reliability in inter‑observers’ manual measurements. 
Dual FA/ICGA angiographic scoring was useful 
in establishing the degree of choroidal and retinal 
involvement in each patient and determining the 
percentage of patients (eyes) with more choroidal 
involvement, more retinal involvement, or equal 
involvement of the choroid and the retina. There was 
no significant difference in the mean angiographic 
scores between the two examiners (7 vs. 7.3 [P = 0.749] 
for FA score and 13.89 vs. 14.15 [P = 0.80] for 
ICG score). The choroid was predominantly involved 
Figure 1. Bar graph showing best‑corrected visual acuity at the 
time of diagnosis of ocular sarcoidosis. The majority of patients 
included had a visual acuity greater than 0.8.
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in 19 patients (82.6%) [Figure 3] and the retina in 
2 patients (8.7%) [Figure 4]. In two patients, one eye had 
predominant retinal involvement and the other eye had 
predominant choroidal involvement. Forty (87%) of the 
46 eyes had more choroidal than retinal lesions, and 
6 (13%) of the 46 eyes had more retinal than choroidal 
lesions [Figure 5].
Eight eyes had negative FA scores (<3 points) but 
positive ICGA scores. In 2 patients, the score was 
negative in one eye. In 3 patients, the FA score was 
negative in both eyes. On the other hand, both eyes 
of one patient had negative ICGA scores and positive 
FA scores. Consequently, the number of patients with 
chorioretinitis (and a diagnosis) that would have been 
missed if only FA had been performed was 3 (11.5%) among 
the 26. If only ICGA had been performed, the number 
of undiagnosed cases would have been 1 (3.8%). When 
the mean angiographic scores were considered, it was 
also noted that choroidal involvement was significantly 
more prevalent than retinal involvement (14.02 ± 4.86 
versus 7.15 ± 4.52 [P < 0.0001]) [Figure 6]. As described 
Figure 2. Bar graph showing results of laser flare photometry 
at the time of diagnosis of ocular sarcoidosis.
Figure 3. Fluorescein and indocyanine green angiographic images of a 66‑year‑old man with ocular sarcoidosis showing 
predominant choroidal involvement. Fluorescein angiography (intermediate angiographic phase) showing macroaneurysms in 
the right eye (top left) with ocular sarcoidosis and appearing normal in the left eye (top right). The fluorescein angiographic score 
was 1 in the right eye and 0 in the left eye. Indocyanine green angiography (late phase) showing both eyes (bottom right and left) 
had numerous hypofluorescent dark dots, indicating presence of occult granulomas that cannot be seen on fundus imaging and 
fluorescein angiography. The indocyanine green angiographic score was 20 in both eyes.
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previously, we verified that lesions in both compartments 
developed independently and at random.[8]
The most frequent angiographic signs were retinal 
vessel staining/leakage, capillary leakage, cystoid 
macular edema, and disc hyperfluorescence for FA. For 
ICGA, the two most frequent signs were fuzzy choroidal 
vessels and hypofluorescent dark dots (HDD).
Using the SUN criteria for vitritis, 80.4% (37/46) of the 
eyes had a vitreous haze score less than 1 [Figure 7]. Of 
the remaining 9 eyes, the vitreous score was 1 in 4 eyes, 
2 in 4 eyes, and 3 in 1 eye.
DISCUSSION
In this study, we performed an assessment of 
sarcoidosis‑related chorioretinitis using dual fluorescein 
angiography/indocyanine green angiography 
(FA/ICGA). The main purpose was to compare between 
the involvement of the retina and that of the choroid. 
For the first time, we have determined specifically and 
objectively the amount of inflammatory angiographic 
Figure 4. Fluorescein and indocyanine green angiographic images of a 43‑year‑old woman with ocular sarcoidosis showing 
predominant retinal involvement. Fluorescein angiography (intermediate angiographic phase) showing optic disc hyperfluorescence 
and retinal vascular staining and leakage in both eyes (top right and left). The fluorescein angiographic score was 7 in the right 
eye and 6.5 in the left eye. Indocyanine green angiography (late phase) showing both eyes (bottom right and left) had small 
hypofluorescent dark areas along the retinal vessel producing a mask effect. The indocyanine green angiographic score was 2 
in both eyes.
Figure 5. Pattern of involvement of each eye in sarcoidosis‑related 
chorioretinitis. Forty (87%) of the 46 eyes had more choroidal 
than retinal lesions, and 6 (13%) of the 46 eyes had more retinal 
than choroidal lesions.
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Figure 6. Bar graph showing pattern of eye involvement 
for each patient with sarcoidosis‑related chorioretinitis at 
the time of diagnosis. Choroidal involvement (ICGA score) 
was significantly more prevalent than retinal involvement 
(FA score).
Figure 7. Bar graph showing vitreous haze at the time of 
diagnosis for each patient using Standardization of Uveitis 
Nomenclature scale. 80.4% (37/46) of the eyes had a vitreous 
haze score less than 1.
lesions in both the retina and the choroid using the 
well‑established dual FA/ICGA angiographic protocol 
and scoring system.[3,4] Furthermore, we determined 
the proportion of cases that were diagnosed with 
sarcoidosis‑related chorioretinitis based on the criteria 
described by the first IWOS.[1] We showed that 
sarcoidosis‑related chorioretinitis involves both the 
retinal and the choroidal structures independently, 
and lesions in one compartment are not a consequence 
of the lesions in the other compartment. This indicates 
that, unlike in Vogt‑Koyanagi‑Harada disease – where 
the choroidal stroma is selectively and exclusively 
generating inflammation with lesions in the other 
structures being the consequence of a spill‑over of 
the choroidal inflammation[9,10] – any eye structure 
can be involved at random in ocular sarcoidosis; the 
ocular structures are innocent bystanders in which the 
systemic disease can produce lesions. The dual FA/ICGA 
angiographic scoring system also showed that choroiditis 
was predominant over retinitis, both in terms of 
intensity (14.00 versus 7.15) and proportion of cases (87%) 
affected. This indicates that ocular involvement can be 
underestimated and a diagnosis can be missed if only FA 
is performed without ICGA. Indeed, in three cases, both 
eyes had an FA score <3 (background signs), whereas the 
ICGA scores were 20, 20, 14, 14, 15, and 18; this meant 
that these patients would have been missed if only FA 
had been performed. If one type of angiography had 
been chosen the false‑negative rate would have been 
twice less for ICGA than for FA.
In 2005, the SUN Working Group[7] proposed an 
adoption of universal criteria in reporting results to the 
Food and Drug Administration (FDA) and for use by 
pharmaceutical companies in designing study protocols. 
However, the Working Group did not integrate the 
new quantitative measurement methods. For posterior 
segment uveitis, the Working Group “rejuvenated” the 
30‑year‑old clinical evaluation of vitreous haze (VH) 
(a subjective method comparing VH to a series of 
graded photographs [0‑4]) as the main outcome measure 
for posterior uveitis trials.[11] Only 19.6% (9/46) of 
the eyes (haze ≥1) in the current study would have 
been included in a posterior uveitis trial based on the 
SUN/FDA criteria [Figure 7]. This outcome measure 
is very subjective, on one hand, and would exclude a 
substantial number of patients with sarcoidosis‑related 
chorioretinitis, on the other hand. In contrast, dual 
FA/ICGA angiographic assessment provides the best 
global information, and it is probably the best modality 
to reach a diagnosis and to monitor disease progression 
or treatment. Indeed, using FA/ICGA allows one to 
obtain global information on chorioretinal inflammation 
at each time point. Moreover, it is much easier to study 
the evolution of the disease by using this combined score 
because the degree of inflammation is quantified, which, 
in addition to VA, IOP and flare, can be used to detect 
the improvement of the chorioretinal lesions. We could 
identify the details of each type of a lesion and determine 
its frequency in sarcoidosis‑related chorioretinitis. In a 
recent study using dual FA/ICGA, similar findings were 
reported in patients with tuberculous chorioretinitis. 
The proportion of eyes with predominant choroidal 
involvement was 72% (39/54).[12] In contrast, a recent 
study in patients with Behçet’s uveitis using the dual 
FA/ICGA scoring system showed that choroidal 
involvement (ICGA score) was insignificant and retinal 
involvement was highly preponderant over choroidal 
involvement in 100% (56/56) of the eyes.[13] This shows 
that FA/ICGA scoring is probably the best modality 
to date to evaluate and monitor posterior uveitis in 
practice and in clinical studies because it allows global 
and quantitative evaluation of inflammation in posterior 
uveitis.
In conclusion, this study assessed and showed for 
the first time the involvement of the retina and the 
choroid in sarcoidosis‑related chorioretinitis. The 
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choroid was preferentially involved, indicating that 
ICGA is the investigation of choice. There is a risk of 
underestimating the global ocular involvement and of 
missing the diagnosis if only FA is used. To evaluate 
correctly intraocular inflammation in sarcoidosis‑related 
chorioretinitis and to conduct a better follow‑up, the use 
of dual FA/ICGA is recommended.
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